Exploratory findings show MOLP-AgNPs inhibit migration in HeLa cervical cancer cells, suggesting future potential in metastatic models.
These exploratory preclinical findings suggest that MOLP-AgNPs exert anti-migratory effects on cervical cancer cells by modulating EMT. Although HeLa is a non-metastatic cell line, this study highlights the potential of MOLP-AgNPs as a promising candidate for further investigation in metastatic cancer models.
No takes yet. Share an insight, caveat, or question.
Fatiha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: